24 Patient Evaluation (0038)  On-study assessments – Tumor measurements (q 6 weeks x 4, then q 12 weeks) – Performance status, weight, quality of life, chemistries (Day 1 of each cycle) – Adverse events, CBCs (weekly)  Follow-up –Post-study chemotherapy – Survival
{}